Collaboration Makes the Diabetes World Go & #039;Round

In the world of diabetes technologies, collaboration is the name of the game. Medtronic and Novo Nordisk are working together to integrate insulin dosing data from future Novo Nordisk smart insulin pens into continuous glucose monitoring (CGM) devices from Medtronic, such as the Guardian Connect system shown above. At the same time, Abbott and Sanofi will be working on tools that combine Abbott's FreeStyle Libre technology with Sanofi's insulin dosing information. "We see incredible power in combining a variety of data points to drive insights that help people living with diabetes make more informed decisions around managing their glucose levels," said Alejandro Galindo, president of the advanced insulin management division within the diabetes group at Medtronic. "Our new agreement with Novo Nordisk, the world’s largest producer of insulin, will streamline the sharing of two of the most important pieces of information – glucose measurements and insulin dosed. With this, Medtronic can further enhance our market-leading analytics and insights to help ease the burden of diabetes." By integrating glucose monitoring and insulin dosing data, people with diabetes and their healthcare professionals and caregivers will be able to automatically track these two important items in a single place, giving people living with diabetes one less thing to think about in the daily management of their condition. Further, being able to view both gluc...
Source: MDDI - Category: Medical Devices Authors: Tags: Business Source Type: news